ESR1 and breast cancer: Interestingly, high Bcl-2 protein expression has been associated with an early grade, slow-proliferating ER+ profile and favorable outcomes in breast cancer, independent of many pathophysiological characteristics such as lymph node status, tumor size, and grade [37].